OTCMKTS:INBP Integrated BioPharma (INBP) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free INBP Stock Alerts $0.22 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.22▼$0.2250-Day Range$0.20▼$0.2552-Week Range$0.17▼$0.40VolumeN/AAverage Volume1,380 shsMarket Capitalization$6.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Integrated BioPharma alerts: Email Address Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW About Integrated BioPharma Stock (OTCMKTS:INBP)Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.Read More INBP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INBP Stock News HeadlinesFebruary 12, 2024 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2023January 17, 2024 | msn.comKBI Biopharma and Argonaut form drug manufacturing allianceMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…January 16, 2024 | businesswire.comKBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug ...January 9, 2024 | msn.comJohnson & Johnson buys San Diego's Ambrx Biopharma for $2BJanuary 4, 2024 | smallbusiness.chron.comWhat Is a Vertically Integrated Business Model?November 10, 2023 | msn.comIntegrated BioPharma reports resultsNovember 9, 2023 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended September 30, 2023March 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…October 7, 2023 | health.usnews.comMaricopa Integrated Health System-PhoenixSeptember 21, 2023 | benzinga.comIntegrated Biopharma Chief Financial Officer Acquires 50,000 Shares After Exercising Company Stock OptionsSeptember 15, 2023 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023May 11, 2023 | msn.comIntegrated BioPharma GAAP EPS of $0.00, revenue of $13.1MMay 11, 2023 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2023March 21, 2023 | finanznachrichten.deIntegrated BioPharma, Inc.: Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and PresidentMarch 21, 2023 | benzinga.comIntegrated BioPharma Announces the Sudden Death of Its Executive Chairman and PresidentMarch 21, 2023 | technews.tmcnet.comKBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After OpeningFebruary 25, 2023 | finance.yahoo.comNew IDBS Polar data science capabilities democratize access to AI/ML-powered insights to accelerate BioPharma process optimizationFebruary 10, 2023 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2022November 10, 2022 | finance.yahoo.comIntegrated BioPharma Reports Results for Its Quarter Ended September 30, 2022October 10, 2022 | msn.comMake in India: PharmNXT Biotech unveils first integrated manufacturing unit for single use bioprocessing systemsSeptember 15, 2022 | seekingalpha.comIntegrated BioPharma GAAP EPS of $0.05, revenue of $13.27MSeptember 13, 2022 | finance.yahoo.comIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022September 8, 2022 | reuters.comIntegrated Biopharma IncJune 21, 2022 | finance.yahoo.comIntegrated BioPharma Announces Change in DirectorsJune 21, 2022 | yahoo.comKiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product CandidateMay 14, 2022 | yahoo.comAs baby formula shortage grows, one company is trying to helpSee More Headlines Receive INBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/12/2024Today3/29/2024Next Earnings (Estimated)5/06/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:INBP CUSIPN/A CIK1016504 Webwww.integratedbiopharma.com Phone(973) 926-0816Fax973-926-1735Employees141Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,000.00 Net Margins-0.76% Pretax Margin-0.73% Return on Equity-2.05% Return on Assets-1.47% Debt Debt-to-Equity RatioN/A Current Ratio2.93 Quick Ratio0.84 Sales & Book Value Annual Sales$50.67 million Price / Sales0.13 Cash Flow$0.04 per share Price / Cash Flow5.87 Book Value$0.63 per share Price / Book0.35Miscellaneous Outstanding Shares30,100,000Free Float16,374,000Market Cap$6.61 million OptionableNot Optionable Beta0.52 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMs. Riva Kay Sheppard (Age 57)Co-CEO & Director Comp: $257.82kMs. Christina Kay (Age 54)Co-CEO & Director Comp: $253.09kMs. Dina L. Masi (Age 63)Senior VP, CFO & Secretary Comp: $281.29kMr. Jamie E. LeveyHead of Investor RelationsKey CompetitorsVaccinexNASDAQ:VCNXSeelos TherapeuticsNASDAQ:SEELInnovus PharmaceuticalsOTCMKTS:INNVDAvenue TherapeuticsNASDAQ:ATXIShuttle PharmaceuticalsNASDAQ:SHPHView All Competitors INBP Stock Analysis - Frequently Asked Questions How have INBP shares performed in 2024? Integrated BioPharma's stock was trading at $0.2452 on January 1st, 2024. Since then, INBP stock has decreased by 10.4% and is now trading at $0.2196. View the best growth stocks for 2024 here. When is Integrated BioPharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our INBP earnings forecast. How were Integrated BioPharma's earnings last quarter? Integrated BioPharma, Inc. (OTCMKTS:INBP) announced its earnings results on Monday, February, 12th. The company reported ($0.01) EPS for the quarter. The company earned $11.51 million during the quarter. Integrated BioPharma had a negative net margin of 0.76% and a negative trailing twelve-month return on equity of 2.05%. How do I buy shares of Integrated BioPharma? Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:INBP) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.